Berlition 300 oral

Roman name

Berlithion # 300 oral

The composition and the form of

1 USD 12 ml solution for injection or 1 tablet, coated bullets contain salt etilendiaminova alfa-lipoeva acid 388 mg (equivalent to 300 mg alfa-lipoeva acid); in the box five ampoules, or contour acheikova packing 10 tablets in a box 3 packaging.

Of drugs

Antioxidant, gepatoproteguoe, gipolipidemicescoe, gipoholesterinemicescoe, desintoksikatine. Activates oxidative decarbauxilirovanie dofamine and alfa-ketokislot regulates lipid and carbohydrate exchange, including cholesterol metabolism. Improves liver function (including detoksicirutuyu), protects it from the exotic and endogenous damage factors. Improves trofiku neurons.

Indications

Polineiropatia (diabetic, etc.).

Pregnancy and lactation

Contraindicated. At the time of treatment should stop breastfeeding.

Contraindications

Hypersensitivity, pregnancy, breast-feeding.

Side-Effects

When a fast in / with a sense of gravity in the head and difficulty breathing, convulsions, diplopia, point bleeding of the skin and mucous membranes, the effects on platelets, the uptake of glucose (hypoglycaemia), allergic reaction (pressing pain, urticaria, eczema, anaphylactic shock, skin manifestations in the place).

Patient interaction

Ters effect tsisplatina increases-gipoglikemicakih drugs. Farmatsevticeski incompatible Solutions fruktozy and glucose solution periods. Activity weakened alcohol.

Dosing and Administration

Treatment should start with the / in the solution Berlition 300 U in the next 2-4 weeks. The 1-2 ampoules drug (12-24 ml), corresponding to 480 mg alfa-lipoeva acid) throw 250 ml physiological 0.9% solution of sodium chloride and introduce drip for about 30 minutes. Later transferred to the long-term supportive therapy drug Berlition 300 oral in the form of tablets in the dose of 300-600 mg / sut.

Directory → Metaboliki → Lipid means → Other means gipolipidemicakie → Berlition 300 oral